Esa Muttonen

Title: Esa Muttonen: Innovator in Inhalation Particle Technology

Introduction

Esa Muttonen is a prominent inventor based in Espoo, Finland. He has made significant contributions to the field of inhalation particle technology, particularly in the treatment of respiratory disorders. With a total of 5 patents to his name, Muttonen's work focuses on improving the efficacy and stability of inhalation medications.

Latest Patents

Muttonen's latest patents include innovative formulations of inhalation particles that incorporate a combination of two or more active ingredients. One notable patent describes crystalline spherical inhalation particles that feature a narrow particle size distribution, rough surfaces, and enhanced stability. These particles are particularly beneficial for administering combination medicaments, such as an anti-inflammatory agent and a bronchodilator, for the treatment of asthma and other respiratory disorders. Another significant patent involves inhalation particles that combine a β2-agonist and a glucocorticosteroid in a predetermined and constant ratio. These particles are also designed to have a narrow particle size distribution and are preferably spherical with rough surfaces, making them effective for treating asthma and similar conditions.

Career Highlights

Esa Muttonen is associated with Orion Corporation, where he continues to develop groundbreaking technologies in inhalation therapy. His work has been instrumental in advancing the treatment options available for patients suffering from respiratory issues.

Collaborations

Muttonen collaborates with talented individuals such as Wiwik Watanabe and Esko I Kauppinen, contributing to a dynamic research environment that fosters innovation.

Conclusion

Esa Muttonen's contributions to inhalation particle technology have the potential to significantly improve the treatment of respiratory disorders. His innovative patents reflect a commitment to enhancing patient care through advanced pharmaceutical formulations.